CN Stock MarketDetailed Quotes

603983 Guangdong Marubi Biotechnology

Watchlist
  • 27.32
  • +1.18+4.51%
Market Closed Sep 27 15:00 CST
10.96BMarket Cap35.90P/E (TTM)

Guangdong Marubi Biotechnology Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
27.65%1.35B
38.73%661.39M
28.52%2.23B
34.34%1.54B
29.64%1.06B
24.58%476.75M
-3.10%1.73B
0.53%1.14B
-6.48%817.18M
-5.31%382.67M
Operating revenue
27.65%1.35B
38.73%661.39M
28.52%2.23B
34.34%1.54B
29.64%1.06B
24.58%476.75M
-3.10%1.73B
0.53%1.14B
-6.48%817.18M
-5.31%382.67M
Other operating revenue
281.37%1.19M
----
-65.23%660.26K
----
-80.63%310.84K
----
-96.87%1.9M
----
-19.34%1.6M
----
Total operating cost
25.64%1.15B
39.32%539.83M
29.33%2.03B
33.24%1.37B
31.20%911.65M
24.73%387.47M
3.08%1.57B
2.87%1.03B
1.91%694.87M
6.78%310.65M
Operating cost
8.19%342.43M
12.47%167.95M
19.17%652.22M
22.31%447.97M
25.78%316.51M
17.21%149.33M
-14.89%547.29M
-14.18%366.25M
-19.86%251.64M
-12.64%127.4M
Operating tax surcharges
-15.34%10.79M
9.02%5.73M
-9.17%22.5M
1.23%17.14M
5.19%12.74M
5.58%5.25M
5.37%24.78M
11.26%16.93M
17.54%12.11M
-11.45%4.97M
Operating expense
39.70%717.49M
64.10%332.65M
41.65%1.2B
48.78%795.5M
42.50%513.59M
41.28%202.71M
14.15%846.16M
10.59%534.68M
14.30%360.41M
21.83%143.48M
Administration expense
-1.81%46.47M
0.31%20.81M
-2.14%108.89M
-7.52%73.19M
-8.56%47.33M
-16.04%20.75M
10.87%111.27M
14.52%79.14M
22.54%51.76M
16.90%24.71M
Financial expense
-1.69%-7.66M
9.18%-3.56M
-13.77%-14.39M
-31.69%-10.73M
-32.26%-7.53M
-26.24%-3.92M
64.69%-12.65M
76.95%-8.15M
76.87%-5.69M
72.13%-3.1M
-Interest expense (Financial expense)
-18.73%2.53M
15.09%1.52M
104.54%6.63M
136.66%5.47M
310.48%3.12M
--1.32M
216.49%3.24M
247.96%2.31M
51.34%759.59K
----
-Interest Income (Financial expense)
3.73%-10.7M
1.28%-5.36M
-32.91%-21.41M
-43.42%-16.15M
-57.72%-11.11M
-46.32%-5.43M
54.58%-16.11M
67.73%-11.26M
71.49%-7.05M
69.70%-3.71M
Research and development
23.62%35.85M
21.70%16.25M
17.69%62.29M
18.56%44.23M
17.67%29M
1.24%13.36M
4.83%52.93M
-2.72%37.31M
0.15%24.64M
12.63%13.19M
Credit Impairment Loss
-143.90%-726.23K
-697.84%-3.82M
213.52%2.42M
226.30%2.29M
872.77%1.65M
456.64%638.83K
-61.10%-2.14M
645.80%702.33K
44.15%-214.08K
34.50%-179.12K
Asset Impairment Loss
-0.46%-5.59M
18.39%-2.24M
-33.84%-13.05M
0.42%-8.04M
-18.04%-5.57M
-37.88%-2.75M
14.93%-9.75M
-11.49%-8.08M
15.24%-4.72M
6.01%-1.99M
Other net revenue
11.59%17.72M
10.21%8.11M
172.87%123.86M
-27.37%22.04M
2.93%15.88M
1.79%7.36M
30.27%45.39M
61.59%30.34M
-19.49%15.43M
165.86%7.23M
Fair value change income
131.31%599.49K
232.80%148.99K
1,240.98%70.98M
-87.76%475.95K
-89.58%259.18K
-96.15%44.77K
766.23%5.29M
-63.38%3.89M
-66.63%2.49M
-42.32%1.16M
Invest income
-6.16%12.9M
-17.95%6.47M
58.55%43.64M
-24.38%20.32M
-10.61%13.75M
9.70%7.88M
11.58%27.52M
844.96%26.87M
1,359.45%15.38M
275.66%7.19M
-Including: Investment income associates
----
----
-3.51%-1.43M
----
----
----
-21.85%-1.38M
----
----
----
Asset deal income
-89.60%892.04
-89.60%892.04
66.65%514.57K
-22.95%8.58K
-22.95%8.58K
-22.95%8.58K
-26.75%308.77K
-72.38%11.13K
--11.13K
--11.13K
Other revenue
82.45%10.54M
392.47%7.56M
-19.90%19.34M
0.58%6.99M
133.20%5.78M
46.95%1.53M
10.13%24.15M
-63.63%6.95M
-86.88%2.48M
-11.86%1.04M
Operating profit
37.28%224.65M
34.19%129.68M
54.02%319.34M
29.29%191.18M
18.81%163.64M
21.94%96.64M
-30.65%207.34M
-6.96%147.88M
-34.75%137.73M
-31.63%79.25M
Add:Non operating Income
-62.06%50.27K
35.87%33.04K
-50.14%242.64K
-51.01%219.04K
-69.75%132.47K
689.73%24.31K
-96.01%486.65K
-96.22%447.14K
-96.29%437.93K
-16.31%3.08K
Less:Non operating expense
-93.32%38.67K
-95.64%19.43K
100.74%2.49M
-44.36%594.39K
7.70%578.66K
32,085.68%445.62K
-21.01%1.24M
-30.57%1.07M
-50.66%537.28K
-98.10%1.38K
Total profit
37.66%224.66M
34.79%129.69M
53.49%317.09M
29.58%190.81M
18.57%163.2M
21.41%96.22M
-33.28%206.58M
-12.98%147.25M
-37.95%137.63M
-31.58%79.25M
Less:Income tax cost
49.58%47.63M
9.94%19.07M
0.88%39.5M
-49.36%16.29M
32.94%31.84M
14.87%17.34M
-42.79%39.15M
-0.96%32.17M
-33.75%23.95M
-11.04%15.1M
Net profit
34.77%177.03M
40.25%110.62M
65.79%277.59M
51.64%174.52M
15.55%131.35M
22.94%78.88M
-30.58%167.43M
-15.84%115.09M
-38.77%113.68M
-35.11%64.16M
Net profit from continuing operation
34.77%177.03M
40.25%110.62M
65.79%277.59M
51.64%174.52M
15.55%131.35M
22.94%78.88M
-30.58%167.43M
-15.84%115.09M
-38.77%113.68M
-35.11%64.16M
Less:Minority Profit
-26.57%490.93K
-102.18%-4.49K
369.12%18.17M
113.99%688.84K
119.74%668.53K
115.56%205.4K
-0.34%-6.75M
6.38%-4.92M
2.60%-3.39M
-4.81%-1.32M
Net profit of parent company owners
35.09%176.54M
40.62%110.63M
48.93%259.42M
44.84%173.83M
11.63%130.68M
20.15%78.67M
-29.74%174.18M
-15.49%120.01M
-38.11%117.07M
-34.61%65.48M
Earning per share
Basic earning per share
33.33%0.44
40.00%0.28
51.16%0.65
43.33%0.43
13.79%0.33
25.00%0.2
-30.65%0.43
-14.29%0.3
-38.30%0.29
-36.00%0.16
Diluted earning per share
33.33%0.44
40.00%0.28
51.16%0.65
43.33%0.43
13.79%0.33
25.00%0.2
-30.65%0.43
-14.29%0.3
-38.30%0.29
-36.00%0.16
Other composite income
-121.79%-12.12K
-56.58%-22.64K
55.82%-94.69K
546.46%12.37K
142.75%55.63K
93.08%-14.46K
78.76%-214.34K
-108.90%-2.77K
-277.48%-130.14K
-534.78%-209.08K
Other composite income of parent company owners
-121.79%-12.12K
-56.58%-22.64K
55.82%-94.69K
546.46%12.37K
142.75%55.63K
93.08%-14.46K
78.33%-214.34K
-108.90%-2.77K
-277.48%-130.14K
-534.78%-209.08K
Total composite income
34.71%177.02M
40.25%110.6M
65.95%277.5M
51.66%174.53M
15.73%131.41M
23.32%78.86M
-30.38%167.22M
-15.86%115.08M
-38.87%113.55M
-35.35%63.95M
Total composite income of parent company owners
35.02%176.52M
40.62%110.61M
49.06%259.32M
44.86%173.84M
11.80%130.74M
20.51%78.66M
-29.55%173.97M
-15.51%120.01M
-38.20%116.94M
-34.85%65.27M
Total composite income of minority owners
-26.57%490.93K
-102.18%-4.49K
369.12%18.17M
113.99%688.84K
119.74%668.53K
115.56%205.4K
-0.05%-6.75M
6.38%-4.92M
2.60%-3.39M
-4.81%-1.32M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 27.65%1.35B38.73%661.39M28.52%2.23B34.34%1.54B29.64%1.06B24.58%476.75M-3.10%1.73B0.53%1.14B-6.48%817.18M-5.31%382.67M
Operating revenue 27.65%1.35B38.73%661.39M28.52%2.23B34.34%1.54B29.64%1.06B24.58%476.75M-3.10%1.73B0.53%1.14B-6.48%817.18M-5.31%382.67M
Other operating revenue 281.37%1.19M-----65.23%660.26K-----80.63%310.84K-----96.87%1.9M-----19.34%1.6M----
Total operating cost 25.64%1.15B39.32%539.83M29.33%2.03B33.24%1.37B31.20%911.65M24.73%387.47M3.08%1.57B2.87%1.03B1.91%694.87M6.78%310.65M
Operating cost 8.19%342.43M12.47%167.95M19.17%652.22M22.31%447.97M25.78%316.51M17.21%149.33M-14.89%547.29M-14.18%366.25M-19.86%251.64M-12.64%127.4M
Operating tax surcharges -15.34%10.79M9.02%5.73M-9.17%22.5M1.23%17.14M5.19%12.74M5.58%5.25M5.37%24.78M11.26%16.93M17.54%12.11M-11.45%4.97M
Operating expense 39.70%717.49M64.10%332.65M41.65%1.2B48.78%795.5M42.50%513.59M41.28%202.71M14.15%846.16M10.59%534.68M14.30%360.41M21.83%143.48M
Administration expense -1.81%46.47M0.31%20.81M-2.14%108.89M-7.52%73.19M-8.56%47.33M-16.04%20.75M10.87%111.27M14.52%79.14M22.54%51.76M16.90%24.71M
Financial expense -1.69%-7.66M9.18%-3.56M-13.77%-14.39M-31.69%-10.73M-32.26%-7.53M-26.24%-3.92M64.69%-12.65M76.95%-8.15M76.87%-5.69M72.13%-3.1M
-Interest expense (Financial expense) -18.73%2.53M15.09%1.52M104.54%6.63M136.66%5.47M310.48%3.12M--1.32M216.49%3.24M247.96%2.31M51.34%759.59K----
-Interest Income (Financial expense) 3.73%-10.7M1.28%-5.36M-32.91%-21.41M-43.42%-16.15M-57.72%-11.11M-46.32%-5.43M54.58%-16.11M67.73%-11.26M71.49%-7.05M69.70%-3.71M
Research and development 23.62%35.85M21.70%16.25M17.69%62.29M18.56%44.23M17.67%29M1.24%13.36M4.83%52.93M-2.72%37.31M0.15%24.64M12.63%13.19M
Credit Impairment Loss -143.90%-726.23K-697.84%-3.82M213.52%2.42M226.30%2.29M872.77%1.65M456.64%638.83K-61.10%-2.14M645.80%702.33K44.15%-214.08K34.50%-179.12K
Asset Impairment Loss -0.46%-5.59M18.39%-2.24M-33.84%-13.05M0.42%-8.04M-18.04%-5.57M-37.88%-2.75M14.93%-9.75M-11.49%-8.08M15.24%-4.72M6.01%-1.99M
Other net revenue 11.59%17.72M10.21%8.11M172.87%123.86M-27.37%22.04M2.93%15.88M1.79%7.36M30.27%45.39M61.59%30.34M-19.49%15.43M165.86%7.23M
Fair value change income 131.31%599.49K232.80%148.99K1,240.98%70.98M-87.76%475.95K-89.58%259.18K-96.15%44.77K766.23%5.29M-63.38%3.89M-66.63%2.49M-42.32%1.16M
Invest income -6.16%12.9M-17.95%6.47M58.55%43.64M-24.38%20.32M-10.61%13.75M9.70%7.88M11.58%27.52M844.96%26.87M1,359.45%15.38M275.66%7.19M
-Including: Investment income associates ---------3.51%-1.43M-------------21.85%-1.38M------------
Asset deal income -89.60%892.04-89.60%892.0466.65%514.57K-22.95%8.58K-22.95%8.58K-22.95%8.58K-26.75%308.77K-72.38%11.13K--11.13K--11.13K
Other revenue 82.45%10.54M392.47%7.56M-19.90%19.34M0.58%6.99M133.20%5.78M46.95%1.53M10.13%24.15M-63.63%6.95M-86.88%2.48M-11.86%1.04M
Operating profit 37.28%224.65M34.19%129.68M54.02%319.34M29.29%191.18M18.81%163.64M21.94%96.64M-30.65%207.34M-6.96%147.88M-34.75%137.73M-31.63%79.25M
Add:Non operating Income -62.06%50.27K35.87%33.04K-50.14%242.64K-51.01%219.04K-69.75%132.47K689.73%24.31K-96.01%486.65K-96.22%447.14K-96.29%437.93K-16.31%3.08K
Less:Non operating expense -93.32%38.67K-95.64%19.43K100.74%2.49M-44.36%594.39K7.70%578.66K32,085.68%445.62K-21.01%1.24M-30.57%1.07M-50.66%537.28K-98.10%1.38K
Total profit 37.66%224.66M34.79%129.69M53.49%317.09M29.58%190.81M18.57%163.2M21.41%96.22M-33.28%206.58M-12.98%147.25M-37.95%137.63M-31.58%79.25M
Less:Income tax cost 49.58%47.63M9.94%19.07M0.88%39.5M-49.36%16.29M32.94%31.84M14.87%17.34M-42.79%39.15M-0.96%32.17M-33.75%23.95M-11.04%15.1M
Net profit 34.77%177.03M40.25%110.62M65.79%277.59M51.64%174.52M15.55%131.35M22.94%78.88M-30.58%167.43M-15.84%115.09M-38.77%113.68M-35.11%64.16M
Net profit from continuing operation 34.77%177.03M40.25%110.62M65.79%277.59M51.64%174.52M15.55%131.35M22.94%78.88M-30.58%167.43M-15.84%115.09M-38.77%113.68M-35.11%64.16M
Less:Minority Profit -26.57%490.93K-102.18%-4.49K369.12%18.17M113.99%688.84K119.74%668.53K115.56%205.4K-0.34%-6.75M6.38%-4.92M2.60%-3.39M-4.81%-1.32M
Net profit of parent company owners 35.09%176.54M40.62%110.63M48.93%259.42M44.84%173.83M11.63%130.68M20.15%78.67M-29.74%174.18M-15.49%120.01M-38.11%117.07M-34.61%65.48M
Earning per share
Basic earning per share 33.33%0.4440.00%0.2851.16%0.6543.33%0.4313.79%0.3325.00%0.2-30.65%0.43-14.29%0.3-38.30%0.29-36.00%0.16
Diluted earning per share 33.33%0.4440.00%0.2851.16%0.6543.33%0.4313.79%0.3325.00%0.2-30.65%0.43-14.29%0.3-38.30%0.29-36.00%0.16
Other composite income -121.79%-12.12K-56.58%-22.64K55.82%-94.69K546.46%12.37K142.75%55.63K93.08%-14.46K78.76%-214.34K-108.90%-2.77K-277.48%-130.14K-534.78%-209.08K
Other composite income of parent company owners -121.79%-12.12K-56.58%-22.64K55.82%-94.69K546.46%12.37K142.75%55.63K93.08%-14.46K78.33%-214.34K-108.90%-2.77K-277.48%-130.14K-534.78%-209.08K
Total composite income 34.71%177.02M40.25%110.6M65.95%277.5M51.66%174.53M15.73%131.41M23.32%78.86M-30.38%167.22M-15.86%115.08M-38.87%113.55M-35.35%63.95M
Total composite income of parent company owners 35.02%176.52M40.62%110.61M49.06%259.32M44.86%173.84M11.80%130.74M20.51%78.66M-29.55%173.97M-15.51%120.01M-38.20%116.94M-34.85%65.27M
Total composite income of minority owners -26.57%490.93K-102.18%-4.49K369.12%18.17M113.99%688.84K119.74%668.53K115.56%205.4K-0.05%-6.75M6.38%-4.92M2.60%-3.39M-4.81%-1.32M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data